References
- Campbell N. P. S., Kelly J. G., Adgey A. A. J., Shanks R. G. Mexiletine in normal volunteers. British Journal of Clinical Pharmacology 1978; 6: 372–373
- Fraser H. S., Mucklow J. C., Murray S., Davies D. S. Assessment of antipyrine kinetics by measurements in saliva. British Journal of Clinical Pharmacology 1976; 3: 321–325
- Gibaldi M., Perrier D. Multicompartment In Pharmacokinetics, 2nd edn, J. Swarbrick. Marcel Dekker, New York 1982, Chapter 2
- Grech-Belanger O., Turgeon J., Gilbert M. Stereoselective disposition of mexiletine in man. British Journal of Clinical Pharmacology 1986; 21: 481–487
- Haselbarth V., Doevendans J. E., Wolf M. Kinetics and bioavailability of mexiletine in healthy subjects. Clinical Pharmacological and Therapeutics 1981; 29: 729–736
- Igwemezie L. Stereoselective HPLC analysis, pharmacokinetics, tissue distribution and pharmacodynamics of mexiletine enantiomers. University of British Columbia. 1989, PhD thesis
- Igwemezie L., Kerr C. R., McErlane K. M. The pharmacokinetics of mexiletine enantiomers in human subjects. Xenobiotica 1989; 19: 677–682
- Kaye C. M., Turner P., Kiddie M. A. Variable pharmacokinetics of mexiletine. Postgraduate Medical Journal 1977; 53: 56–58
- Matin S. B., Wan S. H., Karam J. H. Pharmacokinetics of tolbutamide: prediction by concentration in saliva. Clinical Pharmacology Therapeutics 1974; 16: 1052–1058
- Metzler C. M., Weiner D. L. The NONLIN84 User's Guide. Statistical Consultants, Inc., Edgewood, KYUSA 1974
- Mitchell B. G., Clements J. A., Pottage A., Prescott L. F. Mexiletine disposition: individual variation in response to urine acidification and alkalinization. British Journal of Clinical Pharmacology 1985; 16: 281–284
- McErlane K. M., Igwemezie L., Kerr C. R. Stereoselective serum protein binding of mexiletine enantiomers in man. Research Communications in Chemical Pathological and Pharmacology 1987; 56: 141–144
- Mucklow J. C. The use of saliva in therapeutic drug monitoring—review. Therapeutics and Drug Monitoring 1982; 4: 229–247
- Prescott L. F., Pottage A., Clements J. A. Absorption, distribution, and elimination of mexiletine. Postgraduate Medical Journal 1977; 53: 50–55
- Sedman A. J., Wagner J. G. Autoan—a decision making pharmacokinetic computer program. Publication Distribution Service, Ann Arbor 1976
- Talbot R. G., Julian D. G., Clark R. A., Nielson J. M. M., Prescott L. F. Treatment of ventricular arrhythmias with mexiletine. Lancet 1973; ii: 399–404
- Turgeon J., Grech-Belanger O., Gilbert M. Erythrocyte and serum distribution of mexiletine in man. Biopharmaceutics and Drug Disposition 1987; 8: 571–576